MedPath

UPTAKE MEDICAL CORP

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Sequential Segmental Treatment of Emphysema With Upper Lobe Predominance (STEP-UP) Study

Not Applicable
Completed
Conditions
Emphysema
Interventions
Device: InterVapor® treatment plus Optimal Medical Therapy
Other: Optimal Medical Therapy
First Posted Date
2012-11-01
Last Posted Date
2015-10-29
Lead Sponsor
Uptake Medical Corp
Target Recruit Count
69
Registration Number
NCT01719263
Locations
🇦🇹

Otto-Wagner-Spital, Vienna, Austria

🇦🇺

Royal Adelaide Hospital, Adelaide, South Australia, Australia

🇦🇺

Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia

and more 14 locations

Bronchoscopic Thermal Vapor Ablation (BTVA) for Lung Volume Reduction

Not Applicable
Completed
Conditions
Emphysema
Chronic Obstructive Pulmonary Disease
Interventions
Device: BTVA System
First Posted Date
2010-04-13
Last Posted Date
2012-02-23
Lead Sponsor
Uptake Medical Corp
Target Recruit Count
34
Registration Number
NCT01102712
Locations
🇦🇹

Otto-Wagner Hospital, Wien, Austria

🇦🇹

LKH Klagenfurt, Klagenfurt, Austria

🇦🇺

Prince Charles Hospital, Chermside, Queensland, Australia

and more 7 locations

Bronchoscopic Thermal Vapor Ablation (BTVA) for Lung Volume Reduction

Phase 1
Completed
Conditions
Emphysema
Chronic Obstructive Pulmonary Disease
Interventions
Device: BTVA System
First Posted Date
2009-12-31
Last Posted Date
2012-02-23
Lead Sponsor
Uptake Medical Corp
Target Recruit Count
10
Registration Number
NCT01041586
Locations
🇺🇸

University of Iowa, Iowa City, Iowa, United States

🇺🇸

Swedish Hospital, Seattle, Washington, United States

🇺🇸

John C. Lincoln Hospital, Phoenix, Arizona, United States

© Copyright 2025. All Rights Reserved by MedPath